Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer

A. T. Baron, J. A. Wilken, D. E. Haggstrom, S. T. Goodrich, Nita Jane Maihle

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations

Fingerprint Dive into the research topics of 'Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences